[Interferon in the modulation of the immune response in pyelonephritis caused by Staphylococci and Pseudomonas aeruginosa].
In experiments on mice the influence of mouse serum interferon, type I, on immune response in pyelonephritis caused by staphylococci and P. aeruginosa has been studied. The immunomodulating action of interferon and its therapeutic effectiveness have been shown to depend on the etiology of the disease. When injected intraperitoneally in a dose of 1,000 ED, interferon produces a pronounced therapeutic effect in pyelonephritis caused by P. aeruginosa and no effect in pyelonephritis of staphylococcal etiology. Type I interferon introduced in the dose used in this investigation has no influence on the killer activity of spleen lymphocytes, enhances the activity of the complement and the production of antibodies, produces a leukopenic effect and, depending on the etiology of pyelonephritis, exerts influence on the activity of dehydrogenases, the number of EAC- and E-rosette-forming cells, the oxidation metabolism of neutrophils and their phagocytic activity.
Pavlenko
V A
VA
Rudenko
A V
AV
Maĭdannik
V G
VG
Spivak
N Ia
NIa
Glebova
L P
LP
D000818:Animals; D007370:Interferon Type I / Q000627:therapeutic use*; D008297:Male; D051379:Mice; D010587:Phagocytosis / Q000187:drug effects; D011552:Pseudomonas Infections / Q000276:immunology / Q000628:therapy*; D011704:Pyelonephritis / Q000209:etiology / Q000276:immunology / Q000628:therapy*; D013045:Species Specificity; D013203:Staphylococcal Infections / Q000276:immunology / Q000628:therapy*
D007370:Interferon Type I
Interferon v moduliatsii immunnogo otveta pri stafilokokkovom i sinegnoĭnom pielonefrite.